Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines

Journal of Allergy and Clinical Immunology

Volumn 107, Issue 5 SUPPL., 2001, Pages 871-877

  Giustizieri, Maria Laura ^a   Mascia, Francesca ^a   Frezzolini, Alessandra ^a   De Pità, Ornella ^a   Chinni, Luca M ^a   Giannetti, Alberto ^b   Girolomoni, Giampiero ^a   Pastore, Saveria ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Atopic dermatitis; Chemokines; Cytokines; Inflammation; Keratinocytes; Psoriasis

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PHORBOL 13 ACETATE 12 MYRISTATE; POLYCLONAL ANTIBODY; RANTES; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 4; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; ATOPIC DERMATITIS; CASE REPORT; CELLULAR IMMUNITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FEMALE; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; KERATINOCYTE; MALE; PRIORITY JOURNAL; PSORIASIS; SKIN DISEASE; T LYMPHOCYTE;

EID: 0035003526     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.114707     Document Type: Article

References (34)

1. Leung DYM. Atopic dermatitis: New insights and opportunities for therapeutic interventions. J Allergy Clin Immunol 2000;105:860-76.
2. Bos JD, De Rie MA. The pathogenesis of psoriasis: Immunological facts and speculations. Immunol Today 1999;20:40-6.
3. Grewe M, Bruijnzel-Koomen CAFM, Schopf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T, et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998;19:359-61.
4. Nickoloff BJ, Karabin GD, Barker JN, Griffiths CE, Sarma V, Mitra RS, et al. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol 1991;138:129-40.
5. Ackermann L, Harvima IT. Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM-1 in the epidermis. Arch Dermatol Res 1998;290:353-9.
6. Zlotnik A, Yoshie O. Chemokines: A new classification and their role in immunity. Immunity 2000;12:121-7.
7. Homey B, Zlotnik A. Chemokines in allergy. Curr Opin Immunol 1999;11:626-34.
8. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000;18:593-620.
9. Albanesi C, Cavani A, Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: Synergistic or antagonist effects with IFN-γ and TNF-α.J Immunol 1999;162:494-502.
10. Albanesi C, Scarponi C, Sebastiani S, Cavani A, Federici M, De Pità O, et al. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines. J Immunol 2000;165:1395-402.
11. Niwa Y. Elevated RANTES levels in plasma or skin and decreased plasma IL-10 levels in subsets of patients with severe atopic dermatitis. Arch Dermatol 2000;136:125-6.
12. Raychaudhuri SP, Jiang W-Y, Farber EM, Schall TJ, Ruff MR, Pert CB. Upregulation of RANTES in psoriatic keratinocytes: A possible pathogenic mechanism for psoriasis. Acta Derm Venereol 1999;79:9-11.
13. Zweiman B, Kaplan AP, Tong L, Moskovitz AR. Cytokine levels and inflammatory responses in developing late-phase allergic reactions in the skin. J Allergy Clin Immunol 1997;100:104-9.
14. Gillitzer R, Wolff K, Tong D, Müller C, Yoshimura T, Hartmann AA, et al. MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 1993;101:127-31.
15. Gillitzer R, Berger R, Mielke V, Müller, Wolff K, Stingl G. Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol 1991;95:73-9.
16. Gottlieb AB, Luster AD, Posnett DN, Carter DM. Detection of a γ interferon-induced protein IP-10 in psoriatic plaques. J Exp Med 1988;168:941-8.
17. Li J, Ireland GW, Farthing PM, Thornhill MH. Epidermal and oral keratinocytes are induced to produce RANTES and IL-8 by cytokine stimulation. J Invest Dermatol 1996;106:661-6.
18. Yamada H, Matsukura M, Yudate T, Chinara J, Stingl G, Tezuka T. Enhanced production of RANTES, a eosinophil chemoattractant factor, by cytokine-stimulated epidermal keratinocytes. Int Arch Allergy Immunol 1997;114(Suppl 1):28-32.
19. Albanesi C, Scarponi C, Federici M, Nasorri F, Cavani A, Girolomoni G. Interleukin 17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-γ- and interleukin 4-induced activation of human keratinocytes. J Invest Dermatol 2000;115:81-7.
20. Pastore S, Fanales-Belasio E, Albanesi C, Chinni LM, Giannetti A, Girolomoni G. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. J Clin Invest 1997;99:3009-17.
21. Pastore S, Corinti S, La Placa M, Didona B, Girolomoni G. Interferon-γ promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis. J Allergy Clin Immunol 1998;101:538-44.
22. Pastore S, Giustizieri ML, Mascia F, Giannetti A, Kaushansky K, Girolomoni G. Dysregulated activation of activator protein 1 in keratinocytes of atopic dermatitis patients with enhanced expression of granulocyte/macrophage-colony stimulating factor. J Invest Dermatol 2000; 115:1134-43.
23. Baker BS, Powles AV, Valdimarsson H, Fry L. An altered response by psoriatic keratinocytes to gamma interferon. Scand J Immunol 1988;28:735-40.
24. Nickoloff BJ, Mitra RS, Varani J, Dixit VM, Polverini PJ. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol 1994;144:820-8.
25. Jackson M, Howie SEM, Weller R, Sabin E, Hunter JA, McKenzie RC. Psoriatic keratinocytes show reduced IRF-1 and STAT-1α activation in response to gamma-IFN. FASEB J 1999;13:495-502.
26. Chen S-H, Arany I, Apisarnthanarax N, Rajaraman S, Tyring SK, Horikoshi T, et al. Response of keratinocytes from normal and psoriatic epidermis to interferon-γ differs in the expression of zinc-α2-glycoprotein and cathepsin D. FASEB J 2000;14:565-71.
27. Müller C, Gershenfeld HK, Lobe CG, Okada CY, Bleakley RC, Weissman IL. A high proportion of T lymphocytes that infiltrate H-2 incompatible heart allografts in vivo express genes encoding cytotoxic cell-specific serine-proteases, but do not express the MEL-14-defined lymph node homing receptor. J Exp Med 1988;167:1124-36.
28. + T lymphocytes with regulatory activity. J Immunol 2001;116:996-1002.
29. Nakamura K, Williams IR, Kupper TS. Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): Analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and langerhans cells to skin. J Invest Dermatol 1995;105:635-43.
30. Karpus WJ, Lukacs NW, Kennedy KJ, Smith WS, Hurst SD, Barrett TA. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 1997;158:4129-36.
31. Gu L, Tseng S, Horner RM, Tam C, Loda M, Rollins BJ. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 2000;404:407-11.
32. + lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 2000;115:640-6.
33. Nickel RG, Casolaro V, Wahn U, Beyer K, Barnes KC, Plunkett BS, et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 2000;164:1612-6.
34. Foletta VC, Segal DH, Cohen DR. Transcriptional regulation in the immune system: All roads lead to AP-1. J Leukoc Biol 1998;63:139-52